Extract

The purpose of this study is to assess whether LY2216684 is superior to placebo in the treatment of adult patients with major depressive disorder.

Inclusion criteria

• Depressive Disorder, Major

Country

• Argentina
• Finland
• Poland
• Russian Federation
• United States

Links

• ictrp
• nct